New screening tools: Hospitals are piloting tablet-based cognitive exams and AI-driven brain scan analysis to spot Alzheimer’s signs invisible to human observers. Genetic risk insight: Patients can ...
Learn how AI medical discovery is bridging the gap between lab research and bedside treatments, resulting in faster and more ...
Doctors and patients are gaining an edge in the fight against Alzheimer’s disease by catching early warning signs with new screening methods.
New digital screening: Hospitals are piloting a quick, sensor-equipped cognitive exam that uses AI to detect early Alzheimer’s indicators. Genetics and risk: Genetic testing for APOE variants can help ...
Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and ...
MicroAlgo QAS, by optimizing quantum circuit architectures, can significantly enhance the robustness of VQA in various noisy environments. By automatically searching for suitable circuit designs, QAS ...
Proton exchange membrane fuel cells (PEMFCs) are promising for zero-emission vehicles, but their sub-zero start-up capability remains a major hurdle. Freezing of product water inside the membrane ...
Researchers at the University of Oregon have developed an artificial intelligence tool that can read genetic code the way ...
Many common mental health disorders, including depression and anxiety, are associated with a tendency to internalize problems ...
Every cancer diagnosis begins a deeply personal journey, one shaped by both the disease itself and the individual. Cancer ...
The CMS Collaboration has shown, for the first time, that machine learning can be used to fully reconstruct particle collisions at the LHC. This new approach can reconstruct collisions more quickly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results